These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35471524)

  • 1. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Razak A
    JAMA; 2022 Apr; 327(16):1613. PubMed ID: 35471524
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Zhou P; Han T
    JAMA; 2022 Apr; 327(16):1613-1614. PubMed ID: 35471523
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome-Reply.
    Dargaville PA; Carlin JB; Davis PG;
    JAMA; 2022 Apr; 327(16):1614-1615. PubMed ID: 35471518
    [No Abstract]   [Full Text] [Related]  

  • 4. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

  • 7. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
    Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
    Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Isayama T
    JAMA; 2021 Dec; 326(24):2475-2476. PubMed ID: 34901990
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea.
    Shin JE; Yoon SJ; Lim J; Han J; Eun HS; Park MS; Park KI; Lee SM
    J Korean Med Sci; 2020 Aug; 35(32):e253. PubMed ID: 32808509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On exogenous surfactant therapy.
    Merritt TA; Halliday HL
    Pediatr Pulmonol; 1992 Sep; 14(1):1-3. PubMed ID: 1437336
    [No Abstract]   [Full Text] [Related]  

  • 19. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.